We’re rated Excellent
4.7 out of 5 based on 100 reviews


Our mission is to develop novel technologies that will enable greater access of cell and gene therapies globally. We focus on R&D in next-generation point-of-care devices that will enable rapid, safe and affordable cell and gene therapies.

Current methods are:

Labor and capital intensive
Produce cells that contain residual chemicals that have to be removed in post-processing and that increase the cost and time and reduce the quality of the cells.

Focus areas:

Stem cell (MSC) purification for autologous transplantation T-cell purification for CAR-T therapy Single-patient to industrial scale

As seen on

Fast, reliable and efficient. ARD have solved our R&D problem, that was lingering for years, in two months.

Joshua Cohen


Expert analysis of the market and customer needs. We were able to create a tailored solution that our customers actually wanted and were willing to pay for!



Trusted Partners